Goldman Sachs
IART icon

Goldman Sachs’s Integra LifeSciences IART Stock Holding History

Goldman Sachs’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-73,394
Closed -$1.38M – 7063
2014
Q1 		$1.38M Buy
73,394
+1,223
+2% +$23.6K ﹤0.01% 4347
2013
Q4 		$1.41M Buy
+72,171
New +$1.32M ﹤0.01% 4432

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Goldman Sachs's IART Position: Q2 2026 in Review

Goldman Sachs reduced its Integra LifeSciences (IART) stake by 21% in Q2 2026, selling an estimated $5.64M and leaving 1,473,719 shares worth $26.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Goldman Sachs first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $99.3M in Q4 2021. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Goldman Sachs held 1,473,719 shares of Integra LifeSciences worth $26.5M as of Q2 2026.
  • Goldman Sachs sold 403,031 Integra LifeSciences shares in Q2 2026, an estimated $5.64M.
  • Integra LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2381 holding.
  • Goldman Sachs first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Integra LifeSciences position peaked at $99.3M in Q4 2021.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.